β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies

Abstract

This study provides Class II evidence that in patients with probable DLB, β-amyloid is associated with lower cognitive performance and tau pathology is associated with lower frequency of clinical features of DLB.